Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849199 · ClinicalTrials.gov registry record
Cancer Screening and Prevention Program for High Risk Women
A clinical trial of Breast Cancer and Ovarian Cancer, sponsored by NYU Langone Health.
- Completed
- Registry status
- 1,452
- Enrollment target
- 3
- Study locations
NCT00849199 is a study of Breast Cancer and Ovarian Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 1,452 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT00849199, a study of Breast Cancer and Ovarian Cancer, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 1,452 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to collect information from a large group of women who may have a greater chance to develop cancer because of their own personal history of cancer or because of their family history of cancer.
Conditions Studied
Study Locations (3)
New York
- Bellevue Hospital - New York
- NYU Cancer Center - New York
- NYU Tisch Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,452 participants |
| Start Date | 2001-07 |
| Est. Completion | 2018-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849199
The ClinicalTrials.gov registry entry for NCT00849199 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,452 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (48% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00849199 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00849199 about?
NCT00849199 is a clinical study titled "Cancer Screening and Prevention Program for High Risk Women". The purpose of this study is to collect information from a large group of women who may have a greater chance to develop cancer because of their own personal history of cancer or because of their family history of cancer.
What is the current status of trial NCT00849199?
This trial is currently completed. The enrollment target is 1,452 participants. The study started on 2001-07. Estimated completion is 2018-01.
What conditions does trial NCT00849199 study?
This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer.
Who is sponsoring clinical trial NCT00849199?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00849199 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.